ReviewRNA biology2026

FDA-approved antisense oligonucleotide therapies for duchenne muscular dystrophy: current status and future outlook.

Hidenori Moriyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.